ABSTRACT
Extracts from the European mistletoe (Viscum album L.) exhibit both, cytotoxic properties and pronounced immunomodulating abilities (see Büssing, this book). Mistletoe extracts containing carbohydrate-binding proteins (lectins), thionins (viscotoxins), flavonoids and many other components, but also the mistletoe lectins (ML) by themselves, are targets of clinical studies in cancer treatment and other diseases.
